 | |
| Clinical data | |
|---|---|
| Other names | 4-Fluoro-2,5-dimethoxyphenethylamine; 2,5-Dimethoxy-4-fluorophenethylamine |
| Routes of administration | Oral[1] |
| Drug class | Serotonergic psychedelic;Hallucinogen |
| ATC code |
|
| Legal status | |
| Legal status | |
| Pharmacokinetic data | |
| Onset of action | Unknown[1] |
| Duration of action | Unknown[1] |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider |
|
| UNII | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C10H14FNO2 |
| Molar mass | 199.225 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
2C-F, also known as4-fluoro-2,5-dimethoxyphenethylamine, is apsychedelic drug of thephenethylamine and2C families.[1][2] It is takenorally.[1]
In his bookPiHKAL (Phenethylamines I Have Known and Loved),Alexander Shulgin lists the dose of 2C-F as greater than 250 mgorally and itsduration as unknown.[1] At a dose of 250 mg, 2C-F produces slight and uncertain effects including possible modestclosed-eye visuals and pleasantlethargy.[1]
Very little data exists about the pharmacological properties, metabolism, and toxicity of 2C-F.[1][3]
2C-F may be found as a brownish freebaseoil, or as a white crystalline hydrochloride salt.
Thechemical synthesis of 2C-F has been described.[1]
Analogues of 2C-F include2C-B,2C-I,2C-C,DOF, and25F-NBOMe, among others.[1]
2C-F was first described in the literature byAlexander Shulgin in his 1991 bookPiHKAL (Phenethylamines I Have Known and Loved).[1]
As of October 31, 2016, 2C-F is a controlled substance (Schedule III) in Canada.[4]
